Inside information: Canatu Finland Oy to commence change negotiations
Canatu Plc Company announcement 25 August 26 at 8:58 a.m. EEST
Inside information: Canatu Finland Oy to commence change negotiations
Canatu Finland Oy, a Finnish subsidiary of Canatu Oyj, will commence change negotiations in accordance with the Finnish Act on Co-operation in its Operations function, as well as in its Robotics, Mobility and Defence unit and its Medical Diagnostics unit. The negotiations are conducted on financial and production-related grounds.
The purpose of the change negotiations is to adjust and streamline the Company’s operations in line with its updated strategy and to achieve cost savings that support the Company’s long-term ability to improve the profitability and cash flow of its business.
The negotiations cover all employees of the Operations function, excluding employees of that function’s IT team, all employees of the Robotics, Mobility and Defence unit, and all employees of the Medical Diagnostics unit. If implemented, the planned measures are estimated to potentially result in the termination of employment of up to 17 employees.
The change negotiations will commence on 31 August 2026 and are expected to conclude before mid-October 2026.
Additional information
Mikko Vesterinen, CFO, mikko.vesterinen@canatu.com
Dr. Maximilian Slawinski, CEO, maximilian.slawinski@canatu.com
Certified adviser
DNB Carnegie Investment Bank AB (publ), tel. +46 (0) 8 588 685 70
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a deep technology scaleup company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, robotics, mobility and defense, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling more effective manufacturing of the most advanced chips. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry Deposition by CanatuTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu has 182 personnel employed representing over 35 nationalities, with nearly 20% holding or pursuing doctorates (as of 30 June 2026). Discover more at www.canatu.com and follow us on LinkedIn.
Forward-looking statements
Certain statements in this release are “forward-looking statements”. Forward-looking statements include statements concerning plans, assumptions, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, the Company’s competitive strengths and weaknesses, plans or goals relating to financial position, future operations and development, its business strategy and the anticipated trends in the industry and the political and legal environment in which it operates and other information that is not historical information, such as revenue growth, EBIT growth, cost savings, investments, future cash flow generation, operating profit margin, operating capital expenditure, ratio of net debt and EBIT, revenue, and operating results. In some instances, they can be identified by the use of forward-looking terminology, including the terms “believes”, “intends”, “may”, “will” or “should” or, in each case, their negative or variations on comparable terminology.
Forward-looking statements in this company announcement are based on various assumptions, many of which in turn are based on assumptions. By their very nature, forward-looking statements involve inherent risks, uncertainties and assumptions, both general and specific, and the risk exists that the predictions, forecasts, projections, plans and other forward-looking statements will not be achieved. Given these risks, uncertainties and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Any information, views and forward-looking statements contained in this company announcement speak only as at the date of this company announcement. Save as required by law, the Company or DNB Carnegie Investment Bank AB (publ) do not intend and do not assume any obligation to update or correct any forward-looking statement contained in this company announcement and do not undertake to publish such updates or corrections.